Spectral Medical (OTCMKTS:EDTXF) and TELA Bio (NASDAQ:TELA) Head to Head Analysis

Spectral Medical (OTCMKTS:EDTXF – Get Your Free Report ) and TELA Bio (NASDAQ:TELA – Get Your Free Report ) are both small-cap medical companies, but which is the better business? We’ll compare the two companies based on their risk strength, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation.

Analyst ratings

This is a summary of current ratings and recommendations for Spectral Medical and TELA Bio, as reported by MarketBeat.

TELA Bio has a consensus target price of $10.00, indicating a potential upside of 233.33%. Given TELA Bio’s higher possible upside, analysts plainly believe TELA Bio is more favorable than Spectral Medical.

Insider and institutional ownership

94.3% of TELA Bio shares are owned by institutional investors. 1.5% of Spectral Medical shares are owned by company insiders. Comparatively, 6.0% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and big money managers believe a stock will outperform the market over the long term.

return

This table compares Spectral Medical and TELA Bio’s net margins, return on equity and return on assets.

Risk and volatility

Spectral Medical has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, TELA Bio has a beta of 1.02, suggesting that its stock price is 2 % more volatile than the S&P 500.

Rating and Earnings

This table compares Spectral Medical and TELA Bio’s top-line revenue, earnings per share (EPS) and valuation.

Spectral Medical has higher earnings, but lower revenue than TELA Bio. Spectral Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Summary

TELA Bio beats Spectral Medical in 9 of the 13 factors compared between the two stocks.

About Spectral Medical

(Get a free report)

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland and internationally. The company markets the Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of gram-negative bacterial cell wall components; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins and calibrators for use in research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was established in 1991 and is headquartered in Toronto, Canada.

About TELA Bio

(Get a free report)

TELA Bio, Inc., a commercial-stage medical technology company, is focused on providing soft tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of patient anatomy. The company offers a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and products OviTex PRS Reinforced Tissue Matrix to address unmet needs in plastic and reconstructive surgery, as well as OviTex for laparoscopic and robotic procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended for laparoscopic and robot-assisted use . surgical hernia repair. It markets its products through a single direct sales force, primarily in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.

Get news and reviews for Spectral Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Spectral Medical and related companies with MarketBeat.com’s FREE daily email newsletter.